These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 28714900)

  • 21. [Not Available].
    Buffet C
    Bull Acad Natl Med; 2014 Dec; 198(9):1641-52. PubMed ID: 27356366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease.
    Goossens N; Jornayvaz FR
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28956824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenomic and personalized approaches to tackle nonalcoholic fatty liver disease.
    Lorbek G; Urlep Ž; Rozman D
    Pharmacogenomics; 2016 Jul; 17(11):1273-1288. PubMed ID: 27377717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Transgenerational Nutrition on Nonalcoholic Fatty Liver Disease Development: Interplay between Gut Microbiota, Epigenetics and Immunity.
    Tzeng HT; Lee WC
    Nutrients; 2024 May; 16(9):. PubMed ID: 38732634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic predisposition in nonalcoholic fatty liver disease.
    Sookoian S; Pirola CJ
    Clin Mol Hepatol; 2017 Mar; 23(1):1-12. PubMed ID: 28268262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers.
    Perez-Diaz-Del-Campo N; Riezu-Boj JI; Marin-Alejandre BA; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Milagro FI; Bugianesi E; Tur JA; Martinez JA; Abete I; Zulet MA
    Panminerva Med; 2022 Dec; 64(4):485-496. PubMed ID: 35437302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetics and Epigenetics in the Clinic: Precision Medicine in the Management of Fatty Liver Disease.
    Cespiati A; Youngson NA; Tourna A; Valenti L
    Curr Pharm Des; 2020; 26(10):998-1009. PubMed ID: 31969087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease.
    Kahali B; Halligan B; Speliotes EK
    Semin Liver Dis; 2015 Nov; 35(4):375-91. PubMed ID: 26676813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiome and nonalcoholic fatty liver diseases.
    Zhu L; Baker RD; Baker SS
    Pediatr Res; 2015 Jan; 77(1-2):245-51. PubMed ID: 25310763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances.
    Lau JK; Zhang X; Yu J
    J Pathol; 2017 Jan; 241(1):36-44. PubMed ID: 27757953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease.
    Fisher CP; Kierzek AM; Plant NJ; Moore JB
    World J Gastroenterol; 2014 Nov; 20(41):15070-8. PubMed ID: 25386055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Personalized therapy when tackling nonalcoholic fatty liver disease: a focus on sex, genes, and drugs.
    Skubic C; Drakulić Ž; Rozman D
    Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):831-841. PubMed ID: 29969922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016].
    Pár A; Pár G
    Orv Hetil; 2016 Jun; 157(25):987-94. PubMed ID: 27287838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.
    Nobili V; Alisi A; Musso G; Scorletti E; Calder PC; Byrne CD
    Crit Rev Clin Lab Sci; 2016; 53(2):106-20. PubMed ID: 26463349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic aspects of adult patients with nonalcoholic fatty liver disease.
    Abenavoli L; Milic N; Di Renzo L; Preveden T; Medić-Stojanoska M; De Lorenzo A
    World J Gastroenterol; 2016 Aug; 22(31):7006-16. PubMed ID: 27610012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis.
    Dongiovanni P; Romeo S; Valenti L
    Biomed Res Int; 2015; 2015():460190. PubMed ID: 26273621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet.
    Machado MV; Cortez-Pinto H
    Int J Mol Sci; 2016 Apr; 17(4):481. PubMed ID: 27043550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effects of Metabolic Surgery on Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Clanton J; Subichin M
    Surg Clin North Am; 2016 Aug; 96(4):703-15. PubMed ID: 27473796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of a low fructose and low glycemic index/load (FRAGILE) dietary intervention on indices of liver function, cardiometabolic risk factors, and body composition in children and adolescents with nonalcoholic fatty liver disease (NAFLD).
    Mager DR; Iñiguez IR; Gilmour S; Yap J
    JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):73-84. PubMed ID: 23976771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of diet and nutritional management in non-alcoholic fatty liver disease.
    Fan JG; Cao HX
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():81-7. PubMed ID: 24251710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.